JOURNAL ARTICLE
MULTICENTER STUDY

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

Jan Menne, Martin Nitschke, Robert Stingele, Mariam Abu-Tair, Jan Beneke, Jörn Bramstedt, Jan P Bremer, Reinhard Brunkhorst, Veit Busch, Reinhard Dengler, Günther Deuschl, Klaus Fellermann, Helmut Fickenscher, Christoph Gerigk, Alexander Goettsche, Jobst Greeve, Carsten Hafer, Friedrich Hagenmüller, Hermann Haller, Stefan Herget-Rosenthal, Bernd Hertenstein, Christina Hofmann, Melanie Lang, Jan T Kielstein, Ulrich C Klostermeier, Johannes Knobloch, Markus Kuehbacher, Ulrich Kunzendorf, Hendrik Lehnert, Michael P Manns, Tobias F Menne, Tobias N Meyer, Claus Michael, Thomas Münte, Christine Neumann-Grutzeck, Jens Nuernberger, Hermann Pavenstaedt, Leyla Ramazan, Lutz Renders, Jonas Repenthin, Wolfgang Ries, Axel Rohr, Lars Christian Rump, Ola Samuelsson, Friedhelm Sayk, Bernhard M W Schmidt, Sabine Schnatter, Harald Schöcklmann, Stefan Schreiber, Cay U von Seydewitz, Jürgen Steinhoff, Sylvia Stracke, Sebastian Suerbaum, Andreas van de Loo, Martin Vischedyk, Karin Weissenborn, Peter Wellhöner, Monika Wiesner, Sebastian Zeissig, Jürgen Büning, Mario Schiffer, Tanja Kuehbacher
BMJ: British Medical Journal 2012 July 19, 345: e4565
22815429

OBJECTIVE: To evaluate the effect of different treatment strategies on enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome.

DESIGN: Multicentre retrospective case-control study.

SETTING: 23 hospitals in northern Germany.

PARTICIPANTS: 298 adults with enterohaemorrhagic E coli induced haemolytic uraemic syndrome.

MAIN OUTCOME MEASURES: Dialysis, seizures, mechanical ventilation, abdominal surgery owing to perforation of the bowel or bowel necrosis, and death.

RESULTS: 160 of the 298 patients (54%) temporarily required dialysis, with only three needing treatment long term. 37 patients (12%) had seizures, 54 (18%) required mechanical ventilation, and 12 (4%) died. No clear benefit was found from use of plasmapheresis or plasmapheresis with glucocorticoids. 67 of the patients were treated with eculizumab, a monoclonal antibody directed against the complement cascade. No short term benefit was detected that could be attributed to this treatment. 52 patients in one centre that used a strategy of aggressive treatment with combined antibiotics had fewer seizures (2% v 15%, P = 0.03), fewer deaths (0% v 5%, p = 0.029), required no abdominal surgery, and excreted E coli for a shorter duration.

CONCLUSIONS: Enterohaemorrhagic E coli induced haemolytic uraemic syndrome is a severe self limiting acute condition. Our findings question the benefit of eculizumab and of plasmapheresis with or without glucocorticoids. Patients with established haemolytic uraemic syndrome seemed to benefit from antibiotic treatment and this should be investigated in a controlled trial.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Remove bar
Read by QxMD icon Read
22815429
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"